Incanthera (AQSE:INC) Net Margin %: -14,800.00% (As of Sep. 2025)


What is Incanthera Net Margin %?

Incanthera AQSE:INC Net Margin % is -14,800.00% as of Sep. 2025. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Incanthera ranks worse than 97.04% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Incanthera's Net Income for the six months ended in Sep. 2025 was £-0.89 Mil. Incanthera's Revenue for the six months ended in Sep. 2025 was £0.01 Mil. Therefore, Incanthera's net margin for the quarter that ended in Sep. 2025 was -14,800.00%.

The historical rank and industry rank for Incanthera's Net Margin % or its related term are showing as below:

AQSE:INC' s Net Margin % Range Over the Past 10 Years
Min: -37750   Med: 0   Max: 0
Current: -37750

AQSE:INC's Net Margin % is ranked worse than
97.04% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs AQSE:INC: -37750.00

Incanthera  (AQSE:INC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Incanthera Net Margin % Related Terms

Incanthera Net Margin % Historical Data

* Premium members only.

The historical data trend for Incanthera's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incanthera Net Margin % Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -14,800.00

AQSE:INC vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Incanthera's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Net Margin % distribution charts can be found below:

* The bar in red indicates where Incanthera's Net Margin % falls into.


Incanthera Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Incanthera's Net Margin for the fiscal year that ended in Mar. 2025 is calculated as

Net Margin=Net Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-1.997/0
= %

Incanthera's Net Margin for the quarter that ended in Sep. 2025 is calculated as

Net Margin=Net Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.888/0.006
=-14,800.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -14,800.00% mean?
Incanthera (AQSE:INC) has a Net Margin % of -14,800.00% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Incanthera and its competitors. According to the industry distribution chart, Incanthera ranks #918 out of 946 companies in the Biotechnology industry, placing it in the top 97%.
Is Incanthera's Net Margin % too high?
Incanthera's current Net Margin % is -14,800.00%. Based on the distribution chart, Incanthera ranks #918 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Incanthera's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Incanthera ranks #918 out of 946 companies for Net Margin %. This places Incanthera in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Incanthera and its competitors. Incanthera's current Net Margin % is -14,800.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incanthera stock overvalued right now?
Incanthera (AQSE:INC) has a current Net Margin % of -14,800.00%. The current Net Margin % is -14,800.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Incanthera (AQSE:INC), the current Net Margin % is -14,800.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Incanthera Business Description

Address C/o Gateley Plc, 98 King Street, Manchester, GBR, M2 4WU
Incanthera PLC is clinical stage drug development. It specializes in dermatology and oncology therapeutics. The company has launched a skincare range called Skin + CELL, which addresses and enhances life quality through effective delivery of bioactive ingredients capable of energising the skin's natural repair and defence processes at the cellular level. It has one reportable segment, namely the development of dermatology and pharmaceutical products, within the United Kingdom and Switzerland.